Melinta Therapeutics Triumphs in Patent Dispute Over Antibiotic Injections

Melinta Therapeutics has secured a legal victory in its intellectual property dispute concerning antibiotic injections used to treat infections. The litigation, overseen by a federal judge in Chicago, centered on Melinta’s attempts to invalidate the patents associated with these medical injections. This decision comes in the wake of Melinta’s recent sale of a manufacturing facility to Eli Lilly, a transaction valued at nearly $1 billion. The legal proceedings are closely linked to developments from an antibiotic developer that recently declared bankruptcy. For more details, the original article provides a comprehensive overview here.